- Modern methods of treatment and rehabilitation of children with autism
Modern methods of treatment and rehabilitation of children with autism
Modern Pediatrics. Ukraine. (2024). 8(144): 115-122. doi: 10.15574/SP.2024.8(144).115122
Kiyan O. S.1,2
1Zhytomyr Ivan Franko State University, Ukraine
2Clinic “Brain Stimulation Center”, Bila Tserkva, Ukraine
For citation: Kiyan OS. (2024). Modern methods of treatment and rehabilitation of children with autism. Modern Pediatrics. Ukraine. 8(144): 115-122. doi: 10.15574/SP.2024.8(144).115122.
Article received: Aug 13, 2024. Accepted for publication: Dec 10, 2024.
Autism (Autism Spectrum Disorder (ASD)) has many symptoms and can vary quite widely from complete asociality and atrophy of the speech apparatus to increased sensitivity, vulnerability, and inability to cope with problems, and this, accordingly, is a huge medical and social problem that requires significant efforts to solve. As we live in an era of various technologies that occupy the main place in the development of modernity, particularly in medicine, doctors are finding new methods of treating various diseases, even such as ASD. Therefore, the topic of the work is the use of stem cells and effective methods of rehabilitation for children with ASD, which proves to be quite relevant at present.
Aim – through a systematic literature review, to investigate the effect of stem cells on ASD treatment and determine effective correction methods.
The article presents data on the use of stem cells and their influence on brain areas that cause ASD. It contains data about children with ASD worldwide and in Ukraine. The concept of ASD is described, which human conditions are characteristic of ASD when it is better to use experimental methods in treatment, what are the advantages of stem cells, and the positive results that occur with the use of stem cells. Methods suitable for effective and efficient correction of ASD are also described.
Conclusion. The use of any method for the correction or treatment of ASD must correspond to the individual development of the child. Since there is currently no therapeutic method capable of curing ASD, people with this condition have to follow a special diet, undergo medication treatment and various therapies, but they are not able to completely cure ASD. Correctional methods remain the only way to ease the life of people with ASD.
No conflict of interest was declared by the authors.
Keywords: autism spectrum disorders (ASD), stem cells, mesenchymal stem cells, hippotherapy, ABA therapy (behavioral therapy), floortime.
REFERENCES
1. Aishworiya R, Valica T, Hagerman R, Restrepo B. (2023). An update on psychopharmacological treatment of autism spectrum disorder. Neurotherapeutics. 19(1): 248-262. https://doi.org/10.1007/s13311-022-01183-1; PMid:35029811 PMCid:PMC9130393
2. Badyra B, Sułkowski M, Milczarek O, Majka M. (2020). Mesenchymal stem cells as a multimodal treatment for nervous system diseases. Stem Cells Translational Medicine. 9(10): 1174-1189. https://doi.org/10.1002/sctm.19-0430; PMid:32573961 PMCid:PMC7519763
3. Bocheliuk V, Panov M. (2022). Osoblyvosti orhanizatsii psykhokorektsiinoi roboty z autychnymy ditmy: zarubizhnyi dosvid. Visnyk KhNPU imeni HS Skovorody. Psykholohyia. (65): 235-225. https://doi.org/10.1097/GRF.0000000000000707; PMid:35318984 PMCid:PMC9050836
4. Bocheliuk V, Panov M, Spytska L. (2022). Klinichni proiavy autyzmu, oznaky ta symptomy porushennia. Naukovì perspektivi. 8: 26-34.
5. Bodnar I, Pavlova I, Khamade A. (2020). Physical education of children with autism spectrum disorders: a systematic review of structure and effects of interventional programs. Physiotherapy Quarterly. 28(4): 61-70. https://doi.org/10.5114/pq.2020.96232
6. Borre ED, Myers E, Hamilton Lopez M, Kurtzberg J, Shaz B et al. (2023). The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder. Plos one. 18(4): e0282906. https://doi.org/10.1371/journal.pone.0282906; PMid:37071655 PMCid:PMC10112778
7. Choi KR, Bhakta B, Knight EA, Becerra-Culqui TA, Gahre TL et al. (2022). Patient outcomes after applied behavior analysis for autism Spectrum disorder. Journal of Developmental & Behavioral Pediatrics. 43(1): 9-16. https://doi.org/10.1097/DBP.0000000000000995; PMid:34342287 PMCid:PMC8702444
8. Collacchi B, Pinchaud N, Borgi M, Cirulli F. (2023). Equine-Assisted Activities (EAAs) for Children with Autism Spectrum Disorder (ASD): Positive Effects Revealed Using an Ethological Approach. Applied Sciences. 13(13): 7417. https://doi.org/10.3390/app13137417
9. Collins BE, Neul JL. (2022). Rett syndrome and MECP2 duplication syndrome: disorders of MeCP2 dosage. Neuropsychiatric disease and treatment. 18: 2813-2835. https://doi.org/10.2147/NDT.S371483; PMid:36471747 PMCid:PMC9719276
10. El-Tellawy MM, Ahmad AR, Saad K, Alruwaili TA, AbdelMoneim IM et al. (2022). Effect of hyperbaric oxygen therapy and Tomatis sound therapy in children with autism spectrum disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 113: 110457. https://doi.org/10.1016/j.pnpbp.2021.110457; PMid:34662695
11. Fischer I, Shohat S, Levy G, Bar E, Trangle SS et al. (2022). Hyperbaric oxygen therapy alleviates social behavior dysfunction and neuroinflammation in a mouse model for autism spectrum disorders. International Journal of Molecular Sciences. 23(19): 11077. https://doi.org/10.3390/ijms231911077; PMid:36232395 PMCid:PMC9570008
12. García-Ortiz MV, Torre-Aguilar MJ, Morales-Ruiz T, Gómez-Fernández A, Flores-Rojas K et al. (2021). Analysis of global and local DNA methylation patterns in blood samples of patients with autism spectrum disorder. Frontiers in Pediatrics. 9: 685310. https://doi.org/10.3389/fped.2021.685310; PMid:34676183 PMCid:PMC8524094
13. Genovese A, Butler MG. (2020). Clinical assessment, genetics, and treatment approaches in autism spectrum disorder (ASD). International journal of molecular sciences. 21(13): 4726. https://doi.org/10.3390/ijms21134726; PMid:32630718 PMCid:PMC7369758
14. Guthrie W, Wetherby AM, Woods J, Schatschneider C, Holland RD et al. (2023). The earlier the better: An RCT of treatment timing effects for toddlers on the autism spectrum. Autism. 27(8): 2295-2309. https://doi.org/10.1177/13623613231159153; PMid:36922406 PMCid:PMC10502186
15. Hashem S, Nisar S, Bhat AA, Yadav SK, Azeem MW et al. (2020). Genetics of structural and functional brain changes in autism spectrum disorder. Translational psychiatry. 10(1): 229. https://doi.org/10.1038/s41398-020-00921-3; PMid:32661244 PMCid:PMC7359361
16. Havdahl A, Niarchou M, Starnawska A, Uddin M, van der Merwe C et al. (2021). Genetic contributions to autism spectrum disorder. Psychological medicine. 51(13): 2260-2273. https://doi.org/10.1017/S0033291721000192; PMid:33634770 PMCid:PMC8477228
17. Havreliuk S, Bismak O, Dzhamalov R. (2023). Ohliad modelei rukhovykh porushen u ditei z rozladamy autystychnoho spektra zalezhno vid viku. Sportyvna medytsyna, fizychna terapiia ta erhoterapiia. (2): 140-144.
18. Hemati Alamdarloo G, Mradi H. (2021). The effectiveness of sensory integration intervention on the emotional-behavioral problems of children with autism spectrum disorder. Advances in Autism. 7(2): 152-166. https://doi.org/10.1108/AIA-12-2019-0051
19. Hnoonual A, Plong-On O, Worachotekamjorn J, Charalsawadi C, Limprasert P. (2023). Clinical and molecular characteristics of FMR1 microdeletion in patient with fragile X syndrome and review of the literature. Clinica Chimica Acta. 553: 117728. https://doi.org/10.1016/j.cca.2023.117728; PMid:38142803
20. Hu C, Yang T, Chen J, Dai Y, Wei H et. al. (2024). Phenotypic characteristics and rehabilitation effect of children with regressive autism spectrum disorder: a prospective cohort study. BMC psychiatry. 24(1): 514. https://doi.org/10.1186/s12888-024-05955-1; PMid:39030516 PMCid:PMC11264485
21. Khasawneh MA. (2023). Analysis of the application of pedagogical technology to the learning of children with ASD. International Journal of Special Education. 38(1): 82-89. https://doi.org/10.52291/ijse.2023.38.8
22. Liang Y, Duan L, Xu X, Li X, Liu M et al. (2020). Mesenchymal stem cell-derived exosomes for treatment of autism spectrum disorder. ACS Applied Bio Materials. 3(9): 6384-6393. https://doi.org/10.1021/acsabm.0c00831; PMid:35021769
23. Lutsiv Y, Sharan O. (2024). Rozvytok matematychnykh navychok u ditei z rozladamy autystychnoho spektru v umovakh pochatkovoi shkoly. International Science Journal of Education & Linguistics. 3(4): 36-47.
24. Maksimović S, Marisavljević M, Stanojević N, Ćirović M, Punišić S et al. (2023). Importance of Early Intervention in Reducing Autistic Symptoms and Speech-Language Deficits in Children with Autism Spectrum Disorder. Children. 10(1): 122. https://doi.org/10.3390/children10010122; PMid:36670672 PMCid:PMC9857540
25. Meyer M. (2020). Is Hyperbaric Oxygen Therapy Effective For Treating Autism? The Science Journal of the Lander College of Arts and Sciences 13(2): 10.
26. Nabetani M, Mukai T, Taguchi A. (2023). Cell therapies for autism spectrum disorder based on new pathophysiology: A review. Cell Transplantation. 32: 09636897231163217. https://doi.org/10.1177/09636897231163217; PMid:36999673 PMCid:PMC10069005
27. Noshadian M, Ragerdi Kashani I, Asadi-Golshan R, Zarini D, Ghafari N et al. (2024). Benefits of bone marrow mesenchymal stem cells compared to their conditioned medium in valproic acid-induced autism in rats. Molecular Biology Reports. 51(1): 353. https://doi.org/10.1007/s11033-024-09292-0; PMid:38401030
28. Polishchuk N. (2024). Ipoterapiia yak suchasnyi metod fizkultorno sportyvnoi reabilitatsii. Nauka i tekhnika sohodni. 7: 35.
29. Porodko MI. (2018). Fizychna reabilitatsiia i autyzm. Navchalnyi posibnyk. Lviv: Vydavnychyi tsentr LNU imeni Ivana Franka: 63.
30. Prokopchuk N. (2022). Vykorystannia psykhodiahnostychnykh metodyk CASD ta RER-3 u protsesi vyiavlennia y obstezhennia ditei z autyzmom. New pedagogical thought. 111(3): 58-62. https://doi.org/10.37026/2520-6427-2022-111-3-58-62
31. Radomska YaZ. (2020). Autyzm u ditei ta osoblyvosti yoho proiavu. Rozdil 1. Aktualni problemy sotsialnoi roboty. Zbirnyk naukovykh prats molodykh vchenykh. Khmelnytskyi: 126.
32. Saffari S, Saffari TM, Ulrich DJ, Hovius SE, Shin AY. (2021). The interaction of stem cells and vascularity in peripheral nerve regeneration. Neural Regeneration Research. 16(8): 1510-1517. https://doi.org/10.4103/1673-5374.303009; PMid:33433464 PMCid:PMC8323682
33. Samanta D. (2020). An updated review of tuberous sclerosis complex-associated autism spectrum disorder. Pediatric Neurology. 109: 4-11. https://doi.org/10.1016/j.pediatrneurol.2020.03.008; PMid:32563542
34. Sandhu A, Rawat K, Gautam V, Sharma A, Kumar A et al. (2023). Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder. Brain Research. 1815: 148443. https://doi.org/10.1016/j.brainres.2023.148443; PMid:37290608
35. Sandweiss AJ, Brandt VL, Zoghbi HY. (2020). Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies. The Lancet Neurology. 19(8): 689-698. https://doi.org/10.1016/S1474-4422(20)30217-9; PMid:32702338
36. Sansi A, Nalbant S, Ozer D. (2021). Effects of an inclusive physical activity program on the motor skills, social skills and attitudes of students with and without autism spectrum disorder. Journal of Autism and Developmental Disorders. 51(7): 2254-2270. https://doi.org/10.1007/s10803-020-04693-z; PMid:32940823
37. Shamim S, Khan N, Greene DL, Habiba UE, Umer A. (2023). The promise of autologous and allogeneic cellular therapies in the clinical trials of autism spectrum disorder. Regenerative Medicine. 18(4): 347-361. https://doi.org/10.2217/rme-2022-0176; PMid:36935631
38. Sharma AK, Gokulchandran N, Kulkarni PP, Sane HM, Sharma R et al. (2020). Cell transplantation as a novel therapeutic strategy for autism spectrum disorders: a clinical study. American Journal of Stem Cells. 9(5): 89.
39. Shepel AI, Horoshko VI. (2024). Suchasni tekhnolohii v diahnostytsi ta reabilitatsii rozladiv autystychnoho spektru: analitychnyi ohliad naukovykh informatsiinykh dzherel. Ukraina. Zdorov'ia natsii. (2): 154-160. [Шепель АІ, Горошко ВІ. (2024). Сучасні технології в діагностиці та реабілітації розладів аутистичного спектру: аналітичний огляд наукових інформаційних джерел. Україна. Здоров’я нації. (2): 154-160].
40. Shramm R. (2021). Dytiachyi autyzm i AVA terapiia, shcho gruntuietsia na metodakh prykladnoho analizu povedinky. Kyiv: Tsentr uchbovoi literatury: 140.
41. Styles M, Alsharshani D, Samara M, Alsharshani M, Khattab A et al. (2020). Risk factors, diagnosis, prognosis and treatment of autism. Frontiers in Bioscience. 25(9): 1682-1717. https://doi.org/10.2741/4873; PMid:32472753
42. Sun JM, Kurtzberg J. (2021). Stem cell therapies in cerebral palsy and autism spectrum disorder. Developmental Medicine & Child Neurology. 63(5): 503-510. https://doi.org/10.1111/dmcn.14789; PMid:33398874
43. Villarreal-Martínez L, González-Martínez G, Sáenz-Flores M, Bautista-Gómez AJ, González-Martínez A et al. (2022). Stem cell therapy in the treatment of patients with autism spectrum disorder: a systematic review and meta-analysis. Stem Cell Reviews and Reports. 18(1): 155-164. Epub 2021 Sep 13. https://doi.org/10.1007/s12015-021-10257-0; PMid:34515938
44. Vitomska M. (2021). Suchasni pidkhody do erhoterapii ditei z rozladamy autystychnoho spektra. Ukrainskyi zhurnal medytsyny, biolohii ta sportu. 6(2): 30.
45. Xiao L, Huo X, Wang Y, Li W, Li M, Wang C et al. (2023). A bibliometric analysis of global research status and trends in neuromodulation techniques in the treatment of autism spectrum disorder. BMC psychiatry. 23(1): 183. https://doi.org/10.1186/s12888-023-04666-3; PMid:36941549 PMCid:PMC10026211
46. Zheltova M, Ursulenko Yu. (2023). Kharakterystyka osnovnykh kryteriiv diahnos46.tuvannia ta providni metody korektsii rozladiv autystychnoho spektru. Molodyi vchenyi. 10(122): 83-88. https://doi.org/10.61290/pgsd.v10i2.512
